Hardik Shah
2026.06.11 15:25

๐Ÿ“ข ๐‰๐”๐’๐“ ๐ˆ๐: Novo Nordisk's Wegovy Pill Approved in UK for Weight Management - $Novo Nordisk AS(NVO.US) $Hims & Hers Health(HIMS.US) $Eli Lilly(LLY.US)

๐Ÿ‘‰ ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:

โžค UK approves ๐–๐ž๐ ๐จ๐ฏ๐ฒ ๐ฉ๐ข๐ฅ๐ฅ, oral semaglutide for weight management.

โžค UK becomes ๐„๐ฎ๐ซ๐จ๐ฉ๐ž'๐ฌ ๐Ÿ๐ข๐ซ๐ฌ๐ญ country authorizing the treatment.

โžค Approved for adults with ๐จ๐›๐ž๐ฌ๐ข๐ญ๐ฒ or weight-related conditions.

โžค Medication to be used alongside ๐๐ข๐ž๐ญ and ๐ž๐ฑ๐ž๐ซ๐œ๐ข๐ฌ๐ž.

โžค Novo expects availability via ๐ฉ๐ซ๐ข๐ฏ๐š๐ญ๐ž ๐ฉ๐ซ๐ž๐ฌ๐œ๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง within weeks.

โžค OASIS 4 trial: ๐š๐ฉ๐ฉ๐ซ๐จ๐ฑ๐ข๐ฆ๐š๐ญ๐ž๐ฅ๐ฒ ๐Ÿ๐Ÿ’% weight loss versus 2% placebo.

โžค Treatment-adherent participants achieved ๐š๐ฉ๐ฉ๐ซ๐จ๐ฑ๐ข๐ฆ๐š๐ญ๐ž๐ฅ๐ฒ ๐Ÿ๐Ÿ•% weight loss.

โžค Most common side effects were ๐ ๐š๐ฌ๐ญ๐ซ๐จ๐ข๐ง๐ญ๐ž๐ฌ๐ญ๐ข๐ง๐š๐ฅ symptoms.

โžค About ๐Ÿ•% discontinued treatment due to adverse events.

โžค Approval follows authorizations from ๐…๐ƒ๐€ and ๐”๐€๐„ regulators.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

ยฉ 2026 Longbridge๏ฝœDisclaimer